← All indications
Premature Ejaculation
The emission of SEMEN and seminal fluid during the act of preparation for sexual intercourse, i.e. before there is penetration, or shortly after penetration.
Drugs by status
Approved for this indication (2)
Phase 4 trials (3)
Phase 3 trials (11)
Phase 1 trials (6)
Organizations
Organization Involved with Phase 4 Indications (2)
Organization Involved with Phase 3 Indications (19)
- Symyoo
- Bausch Health Companies
- Pfizer
- Shionogi
- Alza
- MorePharma Corporation
- Plethora Solutions Ltd
- Cairo University
- Duke University
- Kaiser Permanente
- University of Pisa
- Assiut University
- Sohag University
- Jiao Tong University
- Catholic University of Korea
- University of North Carolina at Chapel Hill
- Asociacion Mexicana para la Salud Sexual, A.C.
- Mediroyal Prevention Center
- Johnson and Johnson
Organization Involved with Phase 2 Indications (21)
- Allergan
- CTC Bio, Inc.
- Dong-A Pharmaceutical
- Endo Pharmaceuticals
- GlaxoSmithKline
- Ixchelsis Limited
- Tzu Chi University
- Korea University
- New England Research Institutes
- Seoul National University
- Chonbuk National University
- University of Ulsan
- Yeongnam University
- Hallym University
- ICON
- Novotech
- PHT Corporation
- Chonnam National University
- Sungkyunkwan University
- Yuhan Pharmaceutical Company
- Pusan National University
Organization Involved with Phase 1 Indications (2)
Organization Involved with Other Experimental Indications (4)